PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 3, 2018--
The Medicines Company (NASDAQ:MDCO) today announced that its Chief
Executive Officer, Clive Meanwell, M.D., Ph.D., will present at the 36th
Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018, at
8:30 a.m., Pacific Time, at The Westin St. Francis in San Francisco, CA.
A Q&A breakout session will immediately follow the presentation at 9:00
a.m., Pacific Time.
A live audio webcast of the presentation and the breakout session will
be available in the “Investors” section of The
Medicines Company website, www.themedicinescompany.com,
under “Events/Presentations.” A replay of the presentation and breakout
session will be available for a limited time following the event.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by an
overriding purpose – to save lives, alleviate suffering and contribute
to the economics of healthcare. The Company’s mission is to create
transformational solutions to address the most pressing healthcare needs
facing patients, physicians and providers in cardiovascular care. The
Company is headquartered in Parsippany, New Jersey, with a global
innovation center in California.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180103006098/en/
Source: The Medicines Company
The Medicines Company
Krishna Gorti, M.D., 973-290-6122
President, Investor Relations